Guardant Health
GH
#3260
Rank
C$5.06 B
Marketcap
$40.99
Share price
-3.64%
Change (1 day)
33.29%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$2.25 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are C$2.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$2.15 B2.66%
2022-12-31C$2.10 B5.81%
2021-12-31C$1.98 B70.13%
2020-12-31C$1.16 B680.89%
2019-12-31C$0.14 B75.85%
2018-12-31C$85.07 M97.09%
2017-12-31C$43.16 M-12.88%
2016-12-31C$49.54 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.95 B-57.44%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.92 B-14.44%๐Ÿ‡บ๐Ÿ‡ธ USA